Literature DB >> 4044404

Screening for new antifolates of microbial origin and a new antifolate AM-8402.

S Omura, M Murata, K Kimura, S Matsukura, T Nishihara, H Tanaka.   

Abstract

A screening method was established for new specific inhibitors of folate metabolism. Culture broths of soil isolates were selected based on relative microbial activity. A culture, to be retained, must be active against Enterococcus faecium grown in a medium which contains a limited amount of pteroic acid but lacks activity against the microorganism grown in a medium supplemented with thymidine. By this screening method, three new antibiotics, diazaquinomycins A and B and AM-8402 were selected from eight thousand soil isolates. The isolation and structures of diazaquinomycins have been reported. AM-8402 is a new antifolate active against Gram-positive bacteria and mycoplasmas. It consists of a nanaomycin D moiety as chromophore and a deoxysugar and is structurally related to medermycin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4044404     DOI: 10.7164/antibiotics.38.1016

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Serine hydroxymethyltransferase as a potential target of antibacterial agents acting synergistically with one-carbon metabolism-related inhibitors.

Authors:  Yuko Makino; Chihiro Oe; Kazuya Iwama; Satoshi Suzuki; Akie Nishiyama; Kazuya Hasegawa; Haruka Okuda; Kazushige Hirata; Mariko Ueno; Kumi Kawaji; Mina Sasano; Emiko Usui; Toshiaki Hosaka; Yukako Yabuki; Mikako Shirouzu; Makoto Katsumi; Kazutaka Murayama; Hironori Hayashi; Eiichi N Kodama
Journal:  Commun Biol       Date:  2022-06-23

2.  Total synthesis of diazaquinomycins H and J using double Knorr cyclization in the presence of triisopropylsilane.

Authors:  Allan M Prior; Dianqing Sun
Journal:  RSC Adv       Date:  2019-01-14       Impact factor: 4.036

3.  Diaza-anthracene Antibiotics from a Freshwater-Derived Actinomycete with Selective Antibacterial Activity toward Mycobacterium tuberculosis.

Authors:  Michael W Mullowney; Chang Hwa Hwang; Andrew G Newsome; Xiaomei Wei; Urszula Tanouye; Baojie Wan; Skylar Carlson; Nanthida Joy Barranis; EoghainínÓ hAinmhire; Wei-Lun Chen; Kalyanaraman Krishnamoorthy; John White; Rachel Blair; Hyunwoo Lee; Joanna E Burdette; Pradipsinh K Rathod; Tanya Parish; Sanghyun Cho; Scott G Franzblau; Brian T Murphy
Journal:  ACS Infect Dis       Date:  2015-03-11       Impact factor: 5.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.